Pierre Vandepapelière
Signal active
Chief Executive Officer, Chief Medical Officer and Founder
Bio
Pierre Vandepapelière is a Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics. Pierre Vandepapelière attended Université catholique de Louvain.
Location
N/A
Social
Primary Organization
Amyl Therapeutics
Founded
2020
Employees
1-10
Industry
Biotechnology, Life Science, Health Care, Medical
Jobs history
2
Amyl Therapeutics
Board Member
Invalid date - Current
Amyl Therapeutics
Chief Executive Officer, Chief Medical Officer and Founder
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Pierre Vandepapelière is the Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics, based in Europe. With a background in Biotechnology, Pierre Vandepapelière has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.